BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 17242983)

  • 1. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 Superfamily proteins in marine bivalve cancer and stress biology.
    Walker CW; Van Beneden RJ; Muttray AF; Böttger SA; Kelley ML; Tucker AE; Thomas WK
    Adv Mar Biol; 2011; 59():1-36. PubMed ID: 21724017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63/73 homologues in surf clam: novel signaling motifs and implications for control of expression.
    Cox RL; Stephens RE; Reinisch CL
    Gene; 2003 Nov; 320():49-58. PubMed ID: 14597388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63 in Mytilus galloprovincialis and p53 family members in the phylum Mollusca.
    Stifanić M; Micić M; Ramsak A; Blasković S; Ruso A; Zahn RK; Batel R
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Nov; 154(3):264-73. PubMed ID: 19563905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of p63 and p73 in human cancers.
    Inoue K; Fry EA
    Subcell Biochem; 2014; 85():17-40. PubMed ID: 25201187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invertebrate p53-like mRNA isoforms are differentially expressed in mussel haemic neoplasia.
    Muttray AF; Schulte PM; Baldwin SA
    Mar Environ Res; 2008 Oct; 66(4):412-21. PubMed ID: 18653229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
    Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally-occurring model for human cancer.
    Kelley ML; Winge P; Heaney JD; Stephens RE; Farell JH; Van Beneden RJ; Reinisch CL; Lesser MP; Walker CW
    Oncogene; 2001 Feb; 20(6):748-58. PubMed ID: 11314008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
    Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC
    Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural evolution of p53, p63, and p73: implication for heterotetramer formation.
    Joerger AC; Rajagopalan S; Natan E; Veprintsev DB; Robinson CV; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17705-10. PubMed ID: 19815500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73.
    Venkatanarayan A; Raulji P; Norton W; Flores ER
    Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and phylogenetic comparison of p53 in two distinct mussel species (Mytilus).
    Muttray AF; Cox RL; St-Jean S; van Poppelen P; Reinisch CL; Baldwin SA
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):237-50. PubMed ID: 15886062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C terminus of p53 family proteins is a cell fate determinant.
    Harms KL; Chen X
    Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural diversity of p63 and p73 isoforms.
    Osterburg C; Dötsch V
    Cell Death Differ; 2022 May; 29(5):921-937. PubMed ID: 35314772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.